{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T21:05:28Z","timestamp":1783890328857,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05165-z","type":"journal-article","created":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T08:43:02Z","timestamp":1783845782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antineoplastic effect of piperine compared with doxorubicin via suppressing \u03b3-secretase\/notch pathway in breast cancer cells"],"prefix":"10.1007","volume":"17","author":[{"given":"Maha M.","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed A.","family":"Abosharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian N.","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A. Abd","family":"El-Moneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa M.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"5165_CR1","volume-title":"Patient navigation for early detection, diagnosis and treatment of breast cancer: technical brief","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Patient navigation for early detection, diagnosis and treatment of breast cancer: technical brief. Geneva: World Health Organization; 2024."},{"key":"5165_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"issue":"1","key":"5165_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Therapy. 2025;10(1):49.","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"5165_CR4","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine. 2024;103(3):e36905.","journal-title":"Medicine"},{"issue":"3","key":"5165_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10911-021-09496-1","volume":"26","author":"W Chen","year":"2021","unstructured":"Chen W, et al. Mammary development and breast cancer: a notch perspective. J Mammary Gland Biol Neoplasia. 2021;26(3):309\u201320.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"5165_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target therapy. 2022;7(1):95.","journal-title":"Signal Transduct Target therapy"},{"key":"5165_CR7","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.neo.2024.101041","volume":"57","author":"K Yao","year":"2024","unstructured":"Yao K, et al. Furin, ADAM, and \u03b3-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer. Neoplasia. 2024;57:101041.","journal-title":"Neoplasia"},{"issue":"2","key":"5165_CR8","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1002\/onco.13595","volume":"26","author":"P L\u00f3pez-Nieva","year":"2021","unstructured":"L\u00f3pez-Nieva P, et al. More insights on the use of \u03b3\u2010secretase inhibitors in cancer treatment. Oncologist. 2021;26(2):e298\u2013305.","journal-title":"Oncologist"},{"issue":"22","key":"5165_CR9","doi-asserted-by":"publisher","first-page":"12202","DOI":"10.3390\/ijms252212202","volume":"25","author":"OO Adewale","year":"2024","unstructured":"Adewale OO, et al. The potential of plant polysaccharides and chemotherapeutic drug combinations in the suppression of breast cancer. Int J Mol Sci. 2024;25(22):12202.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5165_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00280-022-04400-y","volume":"89","author":"RE Nicoletto","year":"2022","unstructured":"Nicoletto RE, Ofner CM. Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells. Cancer Chemother Pharmacol. 2022;89(3):285\u2013311.","journal-title":"Cancer Chemother Pharmacol"},{"key":"5165_CR11","doi-asserted-by":"publisher","first-page":"103845","DOI":"10.1016\/j.jddst.2022.103845","volume":"77","author":"C-H Hsiao","year":"2022","unstructured":"Hsiao C-H, et al. Enhanced antitumor effect of doxorubicin through active-targeted nanoparticles in doxorubicin-resistant triple-negative breast cancer. J Drug Deliv Sci Technol. 2022;77:103845.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"5165_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ptr.6855","volume":"35","author":"IU Haq","year":"2021","unstructured":"Haq IU, et al. Piperine: A review of its biological effects. Phytother Res. 2021;35(2):680\u2013700.","journal-title":"Phytother Res"},{"key":"5165_CR13","doi-asserted-by":"publisher","first-page":"772418","DOI":"10.3389\/fphar.2021.772418","volume":"12","author":"S Mitra","year":"2022","unstructured":"Mitra S, et al. Anticancer applications and pharmacological properties of piperidine and piperine: a comprehensive review on molecular mechanisms and therapeutic perspectives. Front Pharmacol. 2022;12:772418.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5165_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ptr.7291","volume":"36","author":"CR Quijia","year":"2022","unstructured":"Quijia CR, Chorilli M. Piperine for treating breast cancer: A review of molecular mechanisms, combination with anticancer drugs, and nanosystems. Phytother Res. 2022;36(1):147\u201363.","journal-title":"Phytother Res"},{"issue":"2","key":"5165_CR15","first-page":"340","volume":"12","author":"CH Trasvi\u00f1a-Arenas","year":"2023","unstructured":"Trasvi\u00f1a-Arenas CH, Ayala Medina LA. Vique-S\u00e1nchez, \u03b3-Secretase Inhibitors Selected by Molecular Docking, to Develop a New Drug Against Alzheimer\u2019s Disease. Rep Biochem Mol Biol. 2023;12(2):340\u20139.","journal-title":"Rep Biochem Mol Biol"},{"key":"5165_CR16","doi-asserted-by":"publisher","first-page":"138735","DOI":"10.1016\/j.ijbiomac.2024.138735","volume":"289","author":"MM Salem","year":"2025","unstructured":"Salem MM, et al. New thiadiazolopyrimidine-ornamented pyrazolones as prospective anticancer candidates via suppressing VEGFR-2\/PI3K\/Akt signaling pathway: Synthesis, characterization, in-silico, and in-vitro studies. Int J Biol Macromol. 2025;289:138735.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5165_CR17","doi-asserted-by":"publisher","first-page":"22146","DOI":"10.1038\/s41598-022-26571-7","volume":"12","author":"MM Salem","year":"2022","unstructured":"Salem MM, Gerges MN, Noser AA. Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS\/PI3K\/Akt\/JNK inhibition in breast carcinoma cells. Sci Rep. 2022;12(1):22146.","journal-title":"Sci Rep"},{"issue":"7","key":"5165_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/md21070404","volume":"21","author":"NM Fahmy","year":"2023","unstructured":"Fahmy NM, et al. Enhanced expression of p53 and suppression of PI3K\/Akt\/mTOR by three red sea algal extracts: Insights on their composition by LC-MS-based metabolic profiling and molecular networking. Mar Drugs. 2023;21(7):404.","journal-title":"Mar Drugs"},{"issue":"1","key":"5165_CR19","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1038\/s41598-024-53517-y","volume":"14","author":"AA Noser","year":"2024","unstructured":"Noser AA, et al. Synthesis and molecular docking simulations of novel azepines based on quinazolinone moiety as prospective antimicrobial and antitumor hedgehog signaling inhibitors. Sci Rep. 2024;14(1):3530.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"5165_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.","journal-title":"J Immunol Methods"},{"key":"5165_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4419-6199-0_9","volume":"676","author":"Z Darzynkiewicz","year":"2010","unstructured":"Darzynkiewicz Z, Halicka HD, Zhao H. Analysis of cellular DNA content by flow and laser scanning cytometry. Adv Exp Med Biol. 2010;676:137\u201347.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"5165_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12645-023-00194-7","volume":"14","author":"T Tan","year":"2023","unstructured":"Tan T, et al. Cabazitaxel-loaded human serum albumin nanoparticles combined with TGF\u03b2-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer. Cancer Nanotechnol. 2023;14(1):70.","journal-title":"Cancer Nanotechnol"},{"issue":"10","key":"5165_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun (Lond). 2022;42(10):913\u201336.","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"5165_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/14740338.2022.2151584","volume":"21","author":"P Di Nardo","year":"2022","unstructured":"Di Nardo P, et al. Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. Exp Opin Drug Saf. 2022;21(11):1341\u201355.","journal-title":"Exp Opin Drug Saf"},{"key":"5165_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom13010093","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, et al. PI3K-AKT-targeting breast cancer treatments: natural products and synthetic compounds. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13010093.","journal-title":"Biomolecules"},{"issue":"1","key":"5165_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2014.11.017","volume":"357","author":"AL Greenshields","year":"2015","unstructured":"Greenshields AL, et al. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 2015;357(1):129\u201340.","journal-title":"Cancer Lett"},{"issue":"1","key":"5165_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.intimp.2014.11.012","volume":"24","author":"J Zhang","year":"2015","unstructured":"Zhang J, et al. Piperine inhibits proliferation of human osteosarcoma cells via G2\/M phase arrest and metastasis by suppressing MMP-2\/-9 expression. Int Immunopharmacol. 2015;24(1):50\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"5165_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/mc.22176","volume":"54","author":"PB Yaffe","year":"2015","unstructured":"Yaffe PB, et al. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog. 2015;54(10):1070\u201385.","journal-title":"Mol Carcinog"},{"issue":"1","key":"5165_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","volume":"25","author":"C-Y Jia","year":"2020","unstructured":"Jia C-Y, et al. A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discovery Today. 2020;25(1):248\u201358.","journal-title":"Drug Discovery Today"},{"issue":"1\u20133","key":"5165_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1\u20133):3\u201325.","journal-title":"Adv Drug Deliv Rev"},{"issue":"20","key":"5165_CR31","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43(20):3714\u20137.","journal-title":"J Med Chem"},{"issue":"1","key":"5165_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/C8MD00472B","volume":"10","author":"L Guan","year":"2019","unstructured":"Guan L, et al. ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2019;10(1):148\u201357.","journal-title":"Medchemcomm"},{"key":"5165_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25010216","author":"D Chen","year":"2020","unstructured":"Chen D, et al. Two natural alkaloids synergistically induce apoptosis in breast cancer cells by inhibiting STAT3 activation. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25010216.","journal-title":"Molecules"},{"issue":"1","key":"5165_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/2221-1691.333211","volume":"12","author":"B Buranrat","year":"2022","unstructured":"Buranrat B, Junking M. Piperine suppresses growth and migration of human breast cancer cells through attenuation of Rac1 expression. Asian Pac J Trop Biomed. 2022;12(1):39\u201346.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1","key":"5165_CR35","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1038\/s41598-019-42357-w","volume":"9","author":"PC Marinello","year":"2019","unstructured":"Marinello PC, et al. Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes. Sci Rep. 2019;9(1):5864.","journal-title":"Sci Rep"},{"issue":"1","key":"5165_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23(1):74\u201388.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5165_CR37","doi-asserted-by":"publisher","first-page":"110644","DOI":"10.1016\/j.fct.2019.110644","volume":"132","author":"VM Grinevicius","year":"2019","unstructured":"Grinevicius VM, et al. CDK2 and Bcl-xL inhibitory mechanisms by docking simulations and anti-tumor activity from piperine enriched supercritical extract. Food Chem Toxicol. 2019;132:110644.","journal-title":"Food Chem Toxicol"},{"key":"5165_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcell.2018.00010","volume":"6","author":"RA Rather","year":"2018","unstructured":"Rather RA, Bhagat M. Cancer chemoprevention and piperine: molecular mechanisms and therapeutic opportunities. Front Cell Dev Biol. 2018;6:10.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"5165_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","volume":"17","author":"Y Pommier","year":"2010","unstructured":"Pommier Y, et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010;17(5):421\u201333.","journal-title":"Chem Biol"},{"issue":"7","key":"5165_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"D Gewirtz","year":"1999","unstructured":"Gewirtz D. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999;57(7):727\u201341.","journal-title":"Biochem Pharmacol"},{"key":"5165_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102204","author":"M BeLow","year":"2020","unstructured":"BeLow M, Osipo C. Notch signaling in breast cancer: a role in drug resistance. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9102204.","journal-title":"Cells"},{"issue":"6","key":"5165_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14562","volume":"103","author":"R Wang","year":"2024","unstructured":"Wang R, Liu H, Sun H. In vitro modulation the Notch pathway by piperine: a therapeutic strategy for docetaxel-resistant and non\u2010resistant prostate cancer. Chem Biol Drug Des. 2024;103(6):e14562.","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"5165_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12291-024-01212-0","volume":"40","author":"H Effat","year":"2025","unstructured":"Effat H, Houseini MEE, Abohashem RS. The combined impact of curcumin: piperine and sorafenib on microRNAs and different pathways in breast cancer cells. Indian J Clin Biochem. 2025;40(1):32\u201345.","journal-title":"Indian J Clin Biochem"},{"issue":"5","key":"5165_CR44","first-page":"4378","volume":"8","author":"Z-L Li","year":"2015","unstructured":"Li Z-L, et al. Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells. Int J Clin Exp Pathol. 2015;8(5):4378.","journal-title":"Int J Clin Exp Pathol"},{"issue":"15","key":"5165_CR45","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.3390\/ijms20153696","volume":"20","author":"W Alshaer","year":"2019","unstructured":"Alshaer W, et al. Downregulation of STAT3, \u03b2-catenin, and notch-1 by single and combinations of siRNA treatment enhance chemosensitivity of wild type and doxorubicin resistant MCF7 breast cancer cells to doxorubicin. Int J Mol Sci. 2019;20(15):3696.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5165_CR46","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.apsb.2021.06.003","volume":"11","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch\/NF-\u03baB and RAS\/RAF\/MEK\/ERK signaling pathway. Acta Pharm Sinica B. 2021;11(9):2819\u201334.","journal-title":"Acta Pharm Sinica B"},{"issue":"5","key":"5165_CR47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s12282-020-01098-9","volume":"27","author":"A Alkaraki","year":"2020","unstructured":"Alkaraki A, et al. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and \u03b2-catenin genes. Breast Cancer. 2020;27(5):989\u201398.","journal-title":"Breast Cancer"},{"issue":"1","key":"5165_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30816","volume":"71","author":"CJ O\u2019Rourke","year":"2020","unstructured":"O\u2019Rourke CJ, et al. Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma. Hepatology. 2020;71(1):196\u2013213.","journal-title":"Hepatology"},{"key":"5165_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030209","author":"N Oikawa","year":"2019","unstructured":"Oikawa N, Walter J. Presenilins and \u03b3-Secretase in membrane proteostasis. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8030209.","journal-title":"Cells"},{"key":"5165_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcdb.2020.02.005","volume":"105","author":"A Escamilla-Ayala","year":"2020","unstructured":"Escamilla-Ayala A, et al. Contribution of the Presenilins in the cell biology, structure and function of \u03b3-secretase. Semin Cell Dev Biol. 2020;105:12\u201326.","journal-title":"Semin Cell Dev Biol"},{"key":"5165_CR51","doi-asserted-by":"publisher","first-page":"105686","DOI":"10.1016\/j.phrs.2021.105686","volume":"169","author":"H Jia","year":"2021","unstructured":"Jia H, et al. Cimigenoside functions as a novel \u03b3-secretase inhibitor and inhibits the proliferation or metastasis of human breast cancer cells by \u03b3-secretase\/Notch axis. Pharmacol Res. 2021;169:105686.","journal-title":"Pharmacol Res"},{"key":"5165_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091369","author":"J Hounjet","year":"2021","unstructured":"Hounjet J, Vooijs M. The role of intracellular trafficking of Notch receptors in ligand-independent Notch activation. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11091369.","journal-title":"Biomolecules"},{"key":"5165_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2019.07.012","volume":"461","author":"BM Krishna","year":"2019","unstructured":"Krishna BM, et al. Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Lett. 2019;461:123\u201331.","journal-title":"Cancer Lett"},{"issue":"1","key":"5165_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI32086","volume":"118","author":"J Sj\u00f6lund","year":"2008","unstructured":"Sj\u00f6lund J, et al. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest. 2008;118(1):217\u201328.","journal-title":"J Clin Invest"},{"issue":"12","key":"5165_CR55","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/sj.bjc.6605034","volume":"100","author":"S Rasul","year":"2009","unstructured":"Rasul S, et al. Inhibition of \u03b3-secretase induces G2\/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer. 2009;100(12):1879\u201388.","journal-title":"Br J Cancer"},{"issue":"2","key":"5165_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/onc.2015.80","volume":"35","author":"S Kim","year":"2016","unstructured":"Kim S, et al. Activation of nuclear PTEN by inhibition of Notch signaling induces G2\/M cell cycle arrest in gastric cancer. Oncogene. 2016;35(2):251\u201360.","journal-title":"Oncogene"},{"key":"5165_CR57","doi-asserted-by":"publisher","first-page":"e00090","DOI":"10.7554\/eLife.00090","volume":"1","author":"B Denard","year":"2012","unstructured":"Denard B, Lee C, Ye J. Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1. Elife. 2012;1:e00090.","journal-title":"Elife"},{"issue":"48","key":"5165_CR58","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103(48):18261\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5165_CR59","doi-asserted-by":"publisher","first-page":"22909","DOI":"10.1038\/s41598-021-01529-3","volume":"11","author":"N Pandya","year":"2021","unstructured":"Pandya N, Kumar A. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer. Sci Rep. 2021;11(1):22909.","journal-title":"Sci Rep"},{"issue":"2","key":"5165_CR60","first-page":"124","volume":"22","author":"J Chen","year":"2002","unstructured":"Chen J, et al. Up-regulation of c-myc expression in MCF-7\/Adr human breast cancer cells and its association with resistance against doxorubicin. Di 1 jun yi da xue xue bao= Acad J first Med Coll PLA. 2002;22(2):124\u20136.","journal-title":"Di 1 jun yi da xue xue bao= Acad J first Med Coll PLA"},{"issue":"4","key":"5165_CR61","first-page":"879","volume":"3","author":"QF Ye","year":"2012","unstructured":"Ye QF, et al. Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. Oncol Lett. 2012;3(4):879\u201384.","journal-title":"Oncol Lett"},{"issue":"3","key":"5165_CR62","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","volume":"66","author":"S Stylianou","year":"2006","unstructured":"Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res. 2006;66(3):1517\u201325.","journal-title":"Cancer Res"},{"issue":"12","key":"5165_CR63","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tcb.2014.08.005","volume":"24","author":"A Kasahara","year":"2014","unstructured":"Kasahara A, Scorrano L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol. 2014;24(12):761\u201370.","journal-title":"Trends Cell Biol"},{"key":"5165_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jddst.2015.08.009","volume":"29","author":"M Pachauri","year":"2015","unstructured":"Pachauri M, Gupta ED, Ghosh PC. Piperine loaded PEG-PLGA nanoparticles: Preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J Drug Deliv Sci Technol. 2015;29:269\u201382.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"5165_CR65","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3892\/ijo.2016.3558","volume":"49","author":"N Pilco-Ferreto","year":"2016","unstructured":"Pilco-Ferreto N, Calaf GM. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol. 2016;49(2):753\u201362.","journal-title":"Int J Oncol"},{"issue":"3","key":"5165_CR66","doi-asserted-by":"publisher","first-page":"351","DOI":"10.15171\/apb.2015.049","volume":"5","author":"S Sharifi","year":"2015","unstructured":"Sharifi S, et al. Doxorubicin changes Bax\/Bcl-xL ratio, caspase-8 and 9 in breast cancer cells. Adv Pharm Bull. 2015;5(3):351.","journal-title":"Adv Pharm Bull"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05165-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05165-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05165-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T21:02:41Z","timestamp":1783890161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05165-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5165"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05165-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was conducted on commercially available cell lines and did not involve human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1011"}}